For instance, MN-siPDL1 is known as a programmed death-ligand 1 (PD-L1) inhibitor, which downregulates PD-L1 to initiate cell apoptosis in the treatment of pancreatic cancer [20]. Here, CD274 is linked to familial pancreatic carcinoma.